A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy
Clinical Trial Information
Trial Contact: Parrimon, Yozandra; Tilme, Linda
IRB No: 16.092.07
Protocol Abbrev: BLI800-502 BowelPrep
Principal Investigator: Devendra I Mehta, MD
Sub Investigators: Bornstein, Jeffrey MD; Horvath, Karoly MD; Jackson, Teri ARNP; Safder, Shaista MD; Raijer, Carolina, ARNP; Smadi, Yamen MD
Phase: Drug: Phase III
Age Group: Pediatric
Secondary Protocol No: BLI800-502
Treatment: BLI800; NuLYTELY
Applicable Disease Sites: Bowel Preparation, GI, colonoscopy
Therapies Involved: Medication
ClinicalTrials.gov ID: NCT02819323
2. Describe the general characteristics (demographic, anthropometric and clinical measures) of patients presenting for weight management and predictors (program format, provider type, and patient-level factors) of program response.
1. Male or female between the ages of 12 to 16 years old.
2. Undergoing colonoscopy for routinely accepted indications.